1. Ertugliflozin to reduce arrhythmic burden in ICD/CRT patients (ERASe-trial). a phase III study. (14th October 2021) Authors: Von Lewinski, D; Tripolt, N; Sourij, H; Oulhaj, A; Gwechenberger, M; Martinek, M; Nuernberg, M; Roithinger, F.X; Steinwender, C; Stuehlinger, M; Rohrer, U; Manninger-Wuenscher, M; Scherr, D Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗